학술논문

Safety and preliminary efficacy of "Ready to administer" cytomegalovirus (CMV)-specific T cells for the treatment of patients with refractory CMV infection
Document Type
Journal
Source
BONE MARROW TRANSPLANTATION; JUL 2017, 52 pS507-pS507, 1p. Supplement: 1
Subject
Language
English
ISSN
14765365